| Michael A Thursby, DO | |
|
318 Waterman Ave, East Providence, RI 02914 | |
| (401) 438-5950 | |
| (401) 435-6700 |
| Full Name | Michael A Thursby |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 28 Years |
| Location | 318 Waterman Ave, East Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669455192 | NPI | - | NPPES |
| 110005090A | Medicaid | MA | |
| 110231848 | Other | RAILROAD MEDI | |
| 405620 | Other | RI | BLUE CHIP |
| 9022203 | Medicaid | RI | |
| 000000037167 | Other | MA | BOSTON MEDICAL |
| 459232 | Other | TUFTS | |
| 692775 | Other | HARVARD PILGRIM | |
| 3100290 | Other | UNITED | |
| J25258 | Other | MA | BLUE CROSS |
| 502 | Other | RI | BLUE CROSS |
| 7484643 | Other | AETNA | |
| 1305389001 | Other | CIGNA | |
| 4132 | Other | NEIGHBORHOOD HLT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 213316 (Massachusetts) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | 00502 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dialysis Center Of Attleboro Llc | Attleboro, MA | Dialysis facility |
| Dialysis Center Of Johnston | Johnston, RI | Dialysis facility |
| Dialysis Center Of East Providence | East providence, RI | Dialysis facility |
| Dialysis Center Of Pawtucket | Pawtucket, RI | Dialysis facility |
| Sturdy Memorial Hospital | Attleboro, MA | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Our Lady Of Fatima Hospital | North providence, RI | Hospital |
| Landmark Medical Center | Woonsocket, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates Inc | 8426061185 | 9 |
| Nephrology Associates Inc | 8426061185 | 9 |
News Archive
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.
One aquarium fish's uncanny ability to regenerate essentially any cell type has given scientists a way to mimic cell loss that occurs in diseases such as Parkinson's and diabetes then watch how the fish make more of them.
Lawmakers home for August recess ran into still more anger at town halls over the proposed health care overhaul.
Loyola University Chicago recently hosted a meeting of more than 60 of the world's leading researchers of a protein that could hold the key to new treatments for heart disease.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
› Verified 5 days ago
| Entity Name | The Providence Community Health Centers Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053313593 PECOS PAC ID: 9335050962 Enrollment ID: O20040608000007 |
News Archive
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.
One aquarium fish's uncanny ability to regenerate essentially any cell type has given scientists a way to mimic cell loss that occurs in diseases such as Parkinson's and diabetes then watch how the fish make more of them.
Lawmakers home for August recess ran into still more anger at town halls over the proposed health care overhaul.
Loyola University Chicago recently hosted a meeting of more than 60 of the world's leading researchers of a protein that could hold the key to new treatments for heart disease.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
› Verified 5 days ago
| Entity Name | Nephrology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366426801 PECOS PAC ID: 8426061185 Enrollment ID: O20060724000322 |
News Archive
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.
One aquarium fish's uncanny ability to regenerate essentially any cell type has given scientists a way to mimic cell loss that occurs in diseases such as Parkinson's and diabetes then watch how the fish make more of them.
Lawmakers home for August recess ran into still more anger at town halls over the proposed health care overhaul.
Loyola University Chicago recently hosted a meeting of more than 60 of the world's leading researchers of a protein that could hold the key to new treatments for heart disease.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael A Thursby, DO 318 Waterman Ave, East Providence, RI 02914-3525 Ph: (401) 438-5950 | Michael A Thursby, DO 318 Waterman Ave, East Providence, RI 02914 Ph: (401) 438-5950 |
News Archive
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.
One aquarium fish's uncanny ability to regenerate essentially any cell type has given scientists a way to mimic cell loss that occurs in diseases such as Parkinson's and diabetes then watch how the fish make more of them.
Lawmakers home for August recess ran into still more anger at town halls over the proposed health care overhaul.
Loyola University Chicago recently hosted a meeting of more than 60 of the world's leading researchers of a protein that could hold the key to new treatments for heart disease.
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
› Verified 5 days ago
Matthew J Franco, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 900 Warren Ave, Suite 401, East Providence, RI 02914 Phone: 800-508-4908 Fax: 401-228-6236 | |
Mr. Michael F Gilson, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave, 2nd Floor, East Providence, RI 02914 Phone: 401-606-1004 Fax: 401-606-1153 | |
Dr. Christopher Song, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave, East Providence, RI 02914 Phone: 401-606-1004 Fax: 401-606-1153 | |
Dr. Ricardo Rafael Correa Marquez, M.D Nephrology Medicare: Medicare Enrolled Practice Location: 900 Warren Avenue, Suite 300, East Providence, RI 02914 Phone: 786-246-5719 | |
May Min, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave Ste 301, East Providence, RI 02914 Phone: 401-606-4260 | |
Prerna Ganjoo, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 318 Waterman Ave, East Providence, RI 02914 Phone: 401-438-5950 Fax: 401-435-6700 | |
Mordecai Jeremiah Stolk, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 318 Waterman Ave, East Providence, RI 02914 Phone: 401-438-5950 Fax: 401-435-6700 |